›연구성과›논문

논문

›연구성과›논문

논문

제목[권영주] COVID‑19 and pulmonary fbrosis: therapeutics in clinical trials, repurposing, and potential development2021-06-25 14:23
카테고리2021

 

LINK(PubMed) : Arch Pharm Res. 2021 May;44(5):499-513

 

  • 제    목 : COVID‑19 and pulmonary fbrosis: therapeutics in clinical trials, repurposing, and potential development
  • 저    자 : Joowon Yim, Hee Hyun Lim, Youngjoo Kwon*
  • 저널명 : Archives of Pharmacal Research  (IF=4.946)
  • 게재년월 : 2021년 5월 
  • DOI : 10.1007/s12272-021-01331-9

 

※ Impact Factor(IF)는 2020 기준임

이전[권영주] Discovery and Biological Evaluations of Halogenated 2,4-Diphenyl Indeno[1,2-b]pyridinol Derivatives as Potent Topoisomerase IIα-Targeted Chemotherapeutic Agents for Breast Cancer
-[권영주] COVID‑19 and pulmonary fbrosis: therapeutics in clinical trials, repurposing, and potential development
다음[권영주] Anticancer Activity of Indeno[1,2-b]-Pyridinol Derivative as a New DNA Minor Groove Binding Catalytic Inhibitor of Topoisomerase IIα
Powered by MangBoard | 워드프레스 쇼핑몰 망보드